右美托咪定复合麻醉对脑肿瘤手术中运动诱发电位的影响
回顾性分析78例接受术中神经电生理监测的脑肿瘤手术患者,比较右美托咪定组(n=40)与对照组(n=38)经颅运动诱发电位和体感诱发电位的监测表现。右美托咪定组经颅运动诱发电位假阳性率高于对照组(27.5% vs 5.3%,P=0.047),且诱发满意经颅运动诱发电位所需的刺激强度和重复频率更高,体感诱发电位两组相当。作者认为使用右美托咪定时应谨慎解读术中监测结果。
要点
- 右美托咪定组经颅运动诱发电位假阳性率高于对照组(27.5% vs 5.3%,P=0.047)。
- 右美托咪定组需更高刺激强度(377.5±48.0 vs 347.1±30.0 mV,P=0.001)和重复频率(6.0±0.2 vs 5.7±0.5 pulse/train,P=0.001)诱发满意经颅运动诱发电位。
- 两组体感诱发电位结果相当;右美托咪定组双侧改变仅见于该组(31.3%,P=0.053)。
核心结论
- 本研究表明右美托咪定对脑肿瘤手术术中神经电生理监测中的经颅运动诱发电位有显著影响,因高假阳性率可能降低监测准确性,使用右美托咪定后的监测结果应谨慎解读。
研究设计与样本
- 回顾性分析78例连续接受术中神经电生理监测的脑肿瘤手术患者,右美托咪定组40例,对照组38例。
主要发现
- 经颅运动诱发电位预测术后运动结局的假阳性率右美托咪定组高于对照组(27.5% vs 5.3%,P=0.047)。
- 双侧改变仅见于右美托咪定组(31.3%;P=0.053)。
- 右美托咪定组诱发满意经颅运动诱发电位所需刺激强度高于对照组(377.5±48.0 vs 347.1±30.0 mV;P=0.001),重复频率也高于对照组(6.0±0.2 vs 5.7±0.5 pulse/train;P=0.001)。
- 两组体感诱发电位结果相当。
- 右美托咪定组假阳性经颅运动诱发电位改变出现于麻醉诱导后222.2±70.5分钟(范围95-342分钟);在脑电双频指数监测下使用右美托咪定的患者(n=12)假阳性率高于对照组(50.5% vs 5.3%;P=0.003)。
临床怎么用
- 作者认为,由于高假阳性率可能降低术中神经电生理监测的准确性,使用右美托咪定后的监测结果应谨慎解读。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Dexmedetomidine (DEX) is used as an adjunct to total intravenous anesthesia. However, its effect on intraoperative neurophysiologic monitoring (IOM) during brain tumor surgery remains controversial. The aim of this study was to explore the effect of DEX on IOM during brain tumor surgery. METHODS: Seventy-eight consecutive patients (DEX group, n = 40; control group, n = 38), who underwent brain tumor surgery with IOM, were retrospectively reviewed. The outcomes included the predictability, laterality of alterations, and stimulation parameters of transcranial motor evoked potentials (tcMEPs) and somatosensory evoked potentials (SSEPs). RESULTS: The predictability of tcMEPs for postoperative motor outcomes showed a higher false-positive rate in the DEX group than in the control group (27.5% vs. 5.3%, P = 0.047). Bilateral alterations were observed only in the DEX group (31.3%; P = 0.053). Compared with the control group, the DEX group required significantly higher intensity (377.5 ± 48.0 vs. 347.1 ± 30.0 mV; P = 0.001) and repetition rate (6.0 ± 0.2 vs. 5.7 ± 0.5 pulse/train; P = 0.001) of transcranial electric stimulation to evoke adequate tcMEPs. The SSEP results were comparable between both groups. In the DEX group, false-positive tcMEPs changes occurred 222.2 ± 70.5 minutes (range, 95-342 minutes) after the induction of anesthesia. In addition, the patients who were administered DEX under bispectral index monitoring (n = 12) showed a significantly higher false-positive rate than shown by the control group (50.5% vs. 5.3%; P = 0.003). CONCLUSIONS: This study showed that DEX had significant effects on tcMEPs during IOM in brain tumor surgery. Because the high false-positive rate could decrease the accuracy of IOM, outcomes after using DEX should be cautiously interpreted.
引用
- Lee WH, Park CK, Park HP, et al. Effect of Dexmedetomidine Combined Anesthesia on Motor evoked Potentials During Brain Tumor Surgery. World Neurosurg. 2018. PMID: 30496923. doi:10.1016/j.wneu.2018.11.152
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。